Cost-effectiveness of an advance notification letter to increase colorectal cancer screening

Cronin, P; Goodall, S; Lockett, T; O'Keefe, CM; Norman, R; Church, J

Cost-effectiveness of an advance notification letter to increase colorectal cancer screening

Cronin, P

Goodall, S

Lockett, T O'Keefe, CM Norman, R

Church, J

Permalink

Publication Type:: Journal Article
Citation:: International Journal of Technology Assessment in Health Care, 2013, 29 (3), pp. 261 - 268
Issue Date:: 2013-07-01

Closed Access

	Filename	Description	Size
	2012000526OK.pdf		354.11 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Cronin, P https://orcid.org/0000-0003-4422-7760	en_US
dc.contributor.author	Goodall, S https://orcid.org/0000-0001-6611-6565	en_US
dc.contributor.author	Lockett, T	en_US
dc.contributor.author	O'Keefe, CM	en_US
dc.contributor.author	Norman, R https://orcid.org/0000-0002-3112-3893	en_US
dc.contributor.author	Church, J	en_US
dc.date.issued	2013-07-01	en_US
dc.identifier.citation	International Journal of Technology Assessment in Health Care, 2013, 29 (3), pp. 261 - 268	en_US
dc.identifier.issn	0266-4623	en_US
dc.identifier.uri	http://hdl.handle.net/10453/23681
dc.description.abstract	Objectives: The aim of this study is to evaluate the cost-effectiveness of a patient-direct mailed advance notification letter on participants of a National Bowel Cancer Screening Program (NBCSP) in Australia, which was launched in August 2006 and offers free fecal occult blood testing to all Australians turning 50, 55, or 65 years of age in any given year. Methods: This study followed a hypothetical cohort of 50-year-old, 55-year-old, and 65-year-old patients undergoing fecal occult blood test (FOBT) screening through a decision analytic Markov model. The intervention compared two strategies: (i) advance letter, NBCSP, and FOBT compared with (ii) NBCSP and FOBT. The main outcome measures were life-years gained (LYG), quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio. Results: An advance notification screening letter would yield an additional 54 per 100,000 colorectal cancer deaths avoided compared with no letter. The estimated cost-effectiveness was $3,976 per LYG and $6,976 per QALY gained. Conclusions: An advance notification letter in the NBCSP may have a significant impact on LYG and cancer deaths avoided. It is cost-effective and offers a feasible strategy that could be rolled out across other screening program at an acceptable cost. © 2013 Cambridge University Press.	en_US
dc.relation.ispartof	International Journal of Technology Assessment in Health Care	en_US
dc.relation.isbasedon	10.1017/S0266462313000226	en_US
dc.subject.classification	Health Policy & Services	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Colorectal Neoplasms	en_US
dc.subject.mesh	Mass Screening	en_US
dc.subject.mesh	Confidence Intervals	en_US
dc.subject.mesh	Markov Chains	en_US
dc.subject.mesh	Patient Compliance	en_US
dc.subject.mesh	Quality-Adjusted Life Years	en_US
dc.subject.mesh	Reminder Systems	en_US
dc.subject.mesh	Cost-Benefit Analysis	en_US
dc.subject.mesh	Victoria	en_US
dc.subject.mesh	Correspondence as Topic	en_US
dc.title	Cost-effectiveness of an advance notification letter to increase colorectal cancer screening	en_US
dc.type	Journal Article
utslib.citation.volume	3	en_US
utslib.citation.volume	29	en_US
utslib.for	140208 Health Economics	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	1402 Applied Economics	en_US
dc.location.activity	England
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Strength - CHERE - Centre for Health Economics Research and Evaluation
utslib.copyright.status	closed_access
pubs.issue	3	en_US
pubs.publication-status	Published	en_US
pubs.volume	29	en_US

Abstract:

Objectives: The aim of this study is to evaluate the cost-effectiveness of a patient-direct mailed advance notification letter on participants of a National Bowel Cancer Screening Program (NBCSP) in Australia, which was launched in August 2006 and offers free fecal occult blood testing to all Australians turning 50, 55, or 65 years of age in any given year. Methods: This study followed a hypothetical cohort of 50-year-old, 55-year-old, and 65-year-old patients undergoing fecal occult blood test (FOBT) screening through a decision analytic Markov model. The intervention compared two strategies: (i) advance letter, NBCSP, and FOBT compared with (ii) NBCSP and FOBT. The main outcome measures were life-years gained (LYG), quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio. Results: An advance notification screening letter would yield an additional 54 per 100,000 colorectal cancer deaths avoided compared with no letter. The estimated cost-effectiveness was $3,976 per LYG and $6,976 per QALY gained. Conclusions: An advance notification letter in the NBCSP may have a significant impact on LYG and cancer deaths avoided. It is cost-effective and offers a feasible strategy that could be rolled out across other screening program at an acceptable cost. © 2013 Cambridge University Press.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/23681